Maria Neves

Prof. Maria Neves

Department of Chemistry and LAQV-REQUIMTE , University of Aveiro, 3810-193 Aveiro, Portugal
orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
HZHaiying Zhang
Haiying Zhang
Daniela FreitasDaniela Freitas
Daniela Freitas
HKHan Sang Kim
Han Sang Kim
KFKristina Fabijanic
Kristina Fabijanic
ZLZhong Li
Zhong Li
DLDavid Lyden
David Lyden
The heterogeneity of exosomal populations has hindered our understanding of their biogenesis, molecular composition, biodistribution and functions. By employing asymmetric flow field-flow fractionation (AF4), we identified two exosome subpopulations (large exosome vesicles, Exo-L, 90–120 nm; small exosome vesicles, Exo-S, 60–80 nm) and discovered an abundant population of non-membranous nanoparticles termed ‘exomeres’ (~35 nm). Exomere proteomic profiling revealed an enrichment in metabolic enzymes and hypoxia, microtubule and coagulation proteins as well as specific pathways, such as glycolysis and mTOR signalling. Exo-S and Exo-L contained proteins involved in endosomal function and secretion pathways, and mitotic spindle and IL-2/STAT5 signalling pathways, respectively. Exo-S, Exo-L and exomeres each had unique N-glycosylation, protein, lipid, DNA and RNA profiles and biophysical properties. These three nanoparticle subsets demonstrated diverse organ biodistribution patterns, suggesting distinct biological functions. This study demonstrates that AF4 can serve as an improved analytical tool for isolating extracellular vesicles and addressing the complexities of heterogeneous nanoparticle subpopulations.

20 January 2010 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ATAnabela Tavares
Anabela Tavares
CCCarla M. B. Carvalho
Carla M. B. Carvalho
Maria Amparo FaustinoMaria Amparo Faustino
Maria Amparo Faustino
Maria NevesMaria Neves
Maria Neves
João ToméJoão Tomé
João Tomé
Adelaide AlmeidaAdelaide Almeida
Adelaide Almeida
Antimicrobial photodynamic therapy (aPDT) has emerged in the clinical field as a potential alternative to antibiotics to treat microbial infections. No cases of microbial viability recovery or any resistance mechanisms against it are yet known. 5,10,15-tris(1-Methylpyridinium-4-yl)-20-(pentafluorophenyl)-porphyrin triiodide (Tri-Py+-Me-PF) was used as photosensitizer. Vibrio fischeri and recombinant Escherichia coli were the studied bacteria. To determine the bacterial recovery after treatment, Tri-Py+-Me-PF (5.0 µM) was added to bacterial suspensions and the samples were irradiated with white light (40 W m-2) for 270 minutes. Then, the samples were protected from light, aliquots collected at different intervals and the bioluminescence measured. To assess the development of resistance after treatment, bacterial suspensions were exposed to white light (25 minutes), in presence of 5.0 μM of Tri-Py+-Me-PF (99.99% of inactivation) and plated. After the first irradiation period, surviving colonies were collected from the plate and resuspended in PBS. Then, an identical protocol was used and repeated ten times for each bacterium. The results suggest that aPDT using Tri-Py+-Me-PF represents a promising approach to efficiently destroy bacteria since after a single treatment these microorganisms do not recover their viability and after ten generations of partially photosensitized cells neither of the bacteria develop resistance to the photodynamic process.

28 January 2014 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
EAEliana Alves
Eliana Alves
Maria Amparo FaustinoMaria Amparo Faustino
Maria Amparo Faustino
Maria NevesMaria Neves
Maria Neves
Angela CunhaAngela Cunha
Angela Cunha
João ToméJoão Tomé
João Tomé
Adelaide AlmeidaAdelaide Almeida
Adelaide Almeida
The emergence of microbial resistance is becoming a global problem in clinical and environmental areas. As such, the development of drugs with novel modes of action will be vital to meet the threat...

20 March 2019 in European Heart Journal
Verified
Journal Article
Closed access
FVFrancesca Vinchi
Francesca Vinchi
GPGraca Porto
Graca Porto
ASAndreas Simmelbauer
Andreas Simmelbauer
SASandro Altamura
Sandro Altamura
SPSara T Passos
Sara T Passos
MMMartina Ulrike Muckenthaler
Martina Ulrike Muckenthaler
Aims: Whether and how iron affects the progression of atherosclerosis remains highly debated. Here, we investigate susceptibility to atherosclerosis in a mouse model (ApoE−/− FPNwt/C326S), which develops the disease in the context of elevated non-transferrin bound serum iron (NTBI). Methods and results: Compared with normo-ferremic ApoE−/− mice, atherosclerosis is profoundly aggravated in iron-loaded ApoE−/− FPNwt/C326S mice, suggesting a pro-atherogenic role for iron. Iron heavily deposits in the arterial media layer, which correlates with plaque formation, vascular oxidative stress and dysfunction. Atherosclerosis is exacerbated by iron-triggered lipid profile alterations, vascular permeabilization, sustained endothelial activation, elevated pro-atherogenic inflammatory mediators, and reduced nitric oxide availability. NTBI causes iron overload, induces reactive oxygen species production and apoptosis in cultured vascular cells, and stimulates massive MCP-1-mediated monocyte recruitment, well-established mechanisms contributing to atherosclerosis. NTBI-mediated toxicity is prevented by transferrin- or chelator-mediated iron scavenging. Consistently, a low-iron diet and iron chelation therapy strongly improved the course of the disease in ApoE−/− FPNwt/C326S mice. Our results are corroborated by analyses of serum samples of haemochromatosis patients, which show an inverse correlation between the degree of iron depletion and hallmarks of endothelial dysfunction and inflammation. Conclusion: Our data demonstrate that NTBI-triggered iron overload aggravates atherosclerosis and unravel a causal link between NTBI and the progression of atherosclerotic lesions. Our findings support clinical applications of iron restriction in iron-loaded individuals to counteract iron-aggravated vascular dysfunction and atherosclerosis.

19 August 2009 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Maria NevesMaria Neves
Maria Neves
XKXiaoLe Kong
XiaoLe Kong
MPMark C. Parkin
Mark C. Parkin
RCRichard Cammack
Richard Cammack
RHRobert Charles Hider
Robert Charles Hider
Citrate is an iron chelator and it has been shown to be the major iron ligand in the xylem sap of plants. Furthermore, citrate has been demonstrated to be an important ligand for the non-transferrin bound iron (NTBI) pool occurring in the plasma of individuals suffering from iron-overload. However, ferric citrate chemistry is complicated and a definitive description of its aqueous speciation at neutral pH remains elusive. X-Ray crystallography data indicates that the alcohol function of citrate (Cit4−) is involved in Fe(III) coordination and that deprotonation of this functional group occurs upon complex formation. The inability to include this deprotonation in the affinity constant calculations has been a major source of divergence between various reports of iron(III)–citrate affinity constants. However the recent determination of the alcoholic pKa of citric acid (H4Cit) renders the reassessment of the ferric citrate system possible. The aqueous speciation of ferric citrate has been investigated by mass spectrometry and EPR spectroscopy. It was observed that the most relevant species are a monoiron dicitrate species and dinuclear and trinuclear oligomeric complexes, the relative concentration of which depends on the solution pH value and the iron : citric acid molar ratio. Spectrophotometric titration was utilized for affinity constant determination and the formation constant for the biologically relevant [Fe(Cit)2]5 − is reported for the first time.

29 November 2016 in Chemical Reviews
Verified
Journal Article
Closed access
Joana  BarataJoana Barata
Joana Barata
Maria NevesMaria Neves
Maria Neves
Maria Amparo FaustinoMaria Amparo Faustino
Maria Amparo Faustino
Augusto C. ToméAugusto C. Tomé
Augusto C. Tomé
JCJosé Cavaleiro
José Cavaleiro